Cite

HARVARD Citation

    Mehlman, C. et al. (2019). Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study. Lung cancer. pp. 149-156. [Online]. 
  
Back to record